Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula
Galderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced that it has received U.S. Food...
Read MorePRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
